Showing results (711-720 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 21, 2025
An Italian cost-utility analysis of 20-valent pneumococcal conjugate vaccine for routine vaccination in infantsMichele Basile, Filippo Rumi, Agostino Fortunato, et al.Journal of Medical Economics|April 18, 2025
U.S. payer budget impact of the Leva Pelvic Health System to improve pelvic floor muscle training as first-line treatment of female urinary incontinence compare to real-world clinical practiceEvelyn Hall, Ayachi Sharma, Thomas F Goss, et al.Journal of Medical Economics|April 1, 2025
Artificial intelligence in key pricing, reimbursement, and market access (PRMA) processes: better, faster, cheaper-can you really pick two?Eva Susanne DietrichJournal of Medical Economics|March 28, 2025
Cost of invasive pneumococcal disease, all-cause pneumonia, and all-cause otitis media among commercial-insured US childrenAhuva Averin, Derek Weycker, Rotem Lapidot, et al.Journal of Medical Economics|May 26, 2025
Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in ColombiaJuan Urrego-Reyes, Carlos Marrugo Arnedo, Hernan Jaramillo, et al.Journal of Medical Economics|May 12, 2025
Cost per remission for mirikizumab versus ustekinumab for moderately to severely active ulcerative colitis treatment from the United States commercial payer perspectiveAnkit Gulati, Neha Mittal, Sunanda Kane, et al.Journal of Medical Economics|February 17, 2026
Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world dataCamilla Porta, Lorenzo Pradelli, Giovanni Cirotto, et al.Journal of Medical Economics|August 21, 2025
Cost effectiveness of CMR over MPS-SPECT: a systematic review of recent trends for diagnosing CADBen Kluge, James Harris, Irene Sánchez-Collado, et al.Journal of Medical Economics|August 21, 2025
Cost savings from prioritization of non-invasive modalities within CAD diagnostic protocols: a systematic reviewBen Kluge, James Harris, Irene Sánchez-Collado, et al.Journal of Medical Economics|January 19, 2026
Cost-effectiveness analysis of a 20-valent pneumococcal conjugate vaccine for pneumococcal disease prevention in the Slovak pediatric populationWarisa Wannaadisai, Thea Paoula Nassar, Peter Šebo, et al.Pageof 241